Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration

Naoko Koike,1 Tsuyoshi Otsuji,1 Akiko Tsumura,1 Katsuaki Miki,1 Yukio Sakai,1 Tetsuya Nishimura,1 Kanji Takahashi21Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan; 2Department of Ophthalmology, Kansai Medical University, Osaka, JapanPurpose: Intravitreal injection...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Koike N, Otsuji T, Tsumura A, Miki K, Sakai Y, Nishimura T, Takahashi K
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2019-07-01
Serie:	Clinical Ophthalmology
Soggetti:	AMD aflibercept ranibizumab switchback anti-VEGF drugs
Accesso online:	https://www.dovepress.com/results-of-switchback-from-ranibizumab-to-aflibercept-in-patients-with-peer-reviewed-article-OPTH
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!